CIPH Ciphergen Biosystems (MM)

FREMONT, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH), will announce Second Quarter 2005 financial results on Monday, August 8, 2005, after market close. At 5:00 p.m. EDT on Monday, August 8, Ciphergen will host its Quarterly Conference Call to discuss Second Quarter 2005 Financial Results. Additionally, a telephone replay of the teleconference will be available for 2 weeks beginning at 6:00 p.m. (EDT) on Monday, August 8, 2005, and can be accessed by dialing Domestic: 1-800-633-8284 or International, +1-402-977-9140, Reservation # 21256951. This call is being webcast by PR Newswire and can be accessed at Ciphergen's web site at http://www.ciphergen.com/. Ciphergen's Diagnostics Division is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Centers(R) for biomarker discovery for new diagnostic tests as well as pharmacoproteomic services for improved drug toxicology, efficacy and theranostic assays. Ciphergen's Biosystems Division develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research, and process proteomics applications. ProteinChip Systems enable protein discovery, characterization, identification and assay development to provide researchers with predictive, multi-marker assay capabilities and a better understanding of biological function at the protein level. Additional information about Ciphergen can be found at http://www.ciphergen.com/. NOTE: Ciphergen and ProteinChip are registered trademarks of Ciphergen Biosystems, Inc. DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Caruthers of Ciphergen Biosystems, Inc., +1-510-505-2297, or Web site: http://www.ciphergen.com/

Copyright